Procedure Consent Questions: Expected Benefit, Alternatives, and Unknowns

By the Regenerative Evidence Guide Team

What to Ask Before You Sign a Consent Form

If you’re considering a regenerative medicine procedure — a stem cell injection, PRP (platelet-rich plasma) treatment, or a similar “regenerative” therapy — the consent conversation is where you find out what’s actually known, what isn’t, and what your other options are. This guide gives you a practical set of questions to bring to that conversation, organized around three things every consent discussion should cover: expected benefit, alternatives, and unknowns.

This is educational information only. It does not tell you whether a specific procedure is right for you, and it is not a substitute for a conversation with a licensed clinician who knows your medical history.

First: A Safety Note Worth Reading Before Any Consent Conversation

Not all products marketed as “regenerative medicine” are approved or studied the way most people assume. According to the U.S. Food and Drug Administration (FDA), many products marketed as stem cell, exosome, or similar regenerative therapies have not been approved by the FDA and have not gone through the clinical trial process that establishes safety and effectiveness for a given condition. The FDA has specifically stated these unapproved products have not been approved to treat conditions such as osteoarthritis, chronic pain, neurological disorders, or cardiovascular disease, and has received reports of serious harm — including blindness, tumor formation, and infections — connected to some unapproved products.

The FDA also notes that a product being listed on ClinicalTrials.gov, or a provider saying a product is “FDA-registered,” does not by itself mean the product is legally marketed or has been proven safe and effective. If you’re unsure whether a product falls into this category, that question — “is this product FDA-approved for this specific use, or is it being offered as part of a registered clinical trial?” — belongs at the very top of your list.

Question Group 1: Expected Benefit

These questions help you separate what has been demonstrated from what is hoped for or theoretical.

What specific outcome is this procedure expected to produce for my condition, and how is that measured (pain scores, imaging, mobility, lab values)?
Is that expected outcome based on results from controlled clinical trials, from case reports or small case series, or mainly from clinical experience and theory?
Has this specific product or procedure been studied for my specific condition, or is the evidence drawn from a different condition or a related but different product?
What percentage of patients in the relevant studies saw meaningful improvement, and over what time frame?
Is this treatment approved by the FDA for my condition, or is it being offered off-label, as part of a registered clinical trial, or outside of FDA oversight entirely?

If a provider cannot point to a specific study, trial registry entry, or published outcome data — and instead describes benefit mainly through testimonials or general theory — that’s useful information, not a reason to panic. It just means the benefit claim rests on a different, weaker kind of evidence, and you can factor that into your decision.

Question Group 2: Alternatives

A consent conversation should cover what else is available, not just the procedure being offered.

What are the established, FDA-approved treatment options for my condition, and how does this procedure compare to them in terms of studied effectiveness?
What happens if I choose to do nothing right now, or wait and monitor my condition instead?
Are there lower-risk or lower-cost options that address the same goal?
If I’ve already tried standard treatments, how does this option’s risk profile differ from what I’ve tried?
Does the provider recommend or discourage a second opinion from a specialist in this specific condition (rather than a specialist in the procedure itself)?

Question Group 3: The Unknowns

Every real medical decision includes gaps in knowledge. Getting the provider to name those gaps out loud is one of the most useful things a consent conversation can do.

What long-term data exists on this specific product or procedure — is there follow-up data past a year, or is most evidence short-term?
What are the known risks and possible side effects, including rare but serious ones?
Is there anything about how this product is manufactured, processed, or sourced that isn’t standardized across providers?
What would count as this treatment “not working,” and what’s the plan if that happens?
Who is responsible for follow-up care and monitoring after the procedure, and for how long?

Known vs. Unknown: A Quick Reference

Use this box as a scratchpad during your consent conversation. Fill in the “known” side with what the provider tells you and can support with a source; leave the “unknown” side for anything they can’t answer or that isn’t yet studied.

Regulatory status — Known: whether the product is FDA-approved, part of a registered trial, or neither. Unknown: anything the provider can’t confirm in writing.
Evidence quality — Known: what type of study supports the benefit claim (large trial, small trial, case series, theory). Unknown: whether results generalize to your specific condition.
Risk profile — Known: documented side effects and complication rates from published sources. Unknown: your individual risk given your health history.
Cost — Known: exact out-of-pocket cost and what it includes. Unknown: whether your specific insurance plan will cover any portion — coverage varies by plan and procedure, so ask directly rather than assuming.

A Practical Next-Step Checklist

Ask the provider for the name of the specific product or procedure, in writing, so you can look it up independently.
Search that product name and your condition on ClinicalTrials.gov to see whether it’s part of a registered trial and whether results have been posted.
Ask specifically whether the product is FDA-approved for your condition or is being offered outside that framework.
Request the expected-benefit evidence in writing, not just verbally, so you can review it at home.
Get a second opinion from a clinician who does not perform or sell the procedure being discussed.
Write down your unanswered questions and bring them back before scheduling anything.

How to Read Study Results If a Provider Shares Them

If a provider points you to a study on ClinicalTrials.gov, it’s worth knowing that ClinicalTrials.gov itself cautions that study results are not meant to be interpreted without expert help — a data table alone can be misleading without context. That’s part of why bringing a second opinion into this process is worth doing, not just an optional extra step.

When results are posted, they’re organized into a consistent set of sections, including:

Participant Flow — how many people started, completed, and dropped out at each stage (a high dropout rate is worth asking about).
Baseline Characteristics — who was in the study (age, sex, and other measures); check whether participants resemble your age, condition, and severity.
Outcome Measures — what was actually measured, for which groups, and (where included) the statistical analysis behind it.
Adverse Events — deaths, serious events, and other side effects reported during the study, broken out by group.
Limitations and Caveats — the study’s own stated weaknesses, often the most informative section.

If a study’s tab says “No Results Posted” or “Results Submitted” instead of showing posted results, that means outcome data isn’t yet publicly available — worth knowing before treating a trial listing as proof of benefit.

Where This Fits in Your Decision

None of this checklist is designed to talk you into or out of a procedure. It’s designed to make sure your conversation with a provider covers expected benefit, real alternatives, and honest unknowns — the three things an informed consent conversation exists to surface. If a provider is unwilling to answer these questions directly or in writing, that reluctance is itself useful information for your decision.

Medical Disclaimer

This article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. It is not a substitute for professional medical consultation. Always seek the advice of a qualified healthcare provider with any questions about a medical condition or procedure. Regenerative Evidence Guide is an independent educational publication and is not affiliated with any clinic, academy, training program, or healthcare provider. If you are experiencing a medical emergency, contact your local emergency services immediately.

Sources: U.S. Food and Drug Administration, “Important Patient and Consumer Information About Regenerative Medicine Therapies | FDA” (content current as of April 2024); ClinicalTrials.gov, “How to Read Study Results | ClinicalTrials.gov (last updated August 18, 2026).

For general background on how clinical evidence works, see this site’s Start Here and How We Research pages.

Last updated: September 2026. By Regenerative Evidence Guide Editorial Team.